Skip to main content
PMC home page
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1969 Jun;98(3):930–937. doi: 10.1128/jb.98.3.930-937.1969

Immunological Responses of the Rat to Mycoplasma arthritidis1

B C Cole a, J F Cahill a, B B Wiley a, J R Ward a
PMCID: PMC315276  PMID: 5305935

Abstract

Arthritis was produced in rats by the intravenous injection of Mycoplasma arthritidis. Metabolic inhibiting antibody and indirect hemagglutinating antibody could not be detected in the sera of arthritic or convalescent animals. Nonmurine species of mycoplasma were capable of inducing metabolic inhibiting antibody in the rat. A hypothesis based upon the possible occurrence of heterogenetic antigens common to M. arthritidis and rat tissue was brought forward to explain these findings. Complement-fixing antibody to M. arthritidis was detected 3 to 4 days after injection and subsequently rose to high levels, depending upon the severity of arthritis and number of organisms injected. Animals that had recovered from intravenous or subcutaneous inoculation with M. arthritidis were resistant to subsequent infections by the organism. Immunity could be passively transferred by the intravenous injection of convalescent serum. Adsorption of the convalescent serum with antigen greatly reduced the complement fixation titer but did not significantly alter the protective properties of the serum. The presence of complement-fixing antibody could not be related to the development of immunity. An avirulent strain of M. arthritidis and a strain previously classified as M. hominis type 2 were capable of inducing resistance to subsequent injection by virulent M. arthritidis.

Full text

PDF
933

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker L. F., Patt J. K. Role of complement in immune inactivation of Mycoplasma gallisepticum. J Bacteriol. 1967 Aug;94(2):403–408. doi: 10.1128/jb.94.2.403-408.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. CHANOCK R. M., HAYFLICK L., BARILE M. F. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO. Proc Natl Acad Sci U S A. 1962 Jan 15;48:41–49. doi: 10.1073/pnas.48.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cole B. C., Golightly L., Ward J. R. Characterization of mycoplasma strains from cats. J Bacteriol. 1967 Nov;94(5):1451–1458. doi: 10.1128/jb.94.5.1451-1458.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cole B. C., Miller M. L., Ward J. R. A comparative study on the virulence of Mycoplasma arthritidis and "Mycoplasma hominis, type 2" strains in rats. Proc Soc Exp Biol Med. 1967 Jan;124(1):103–107. doi: 10.3181/00379727-124-31676. [DOI] [PubMed] [Google Scholar]
  5. Diaz R., Jones L. M., Leong D., Wilson J. B. Differences between Brucella antigens involved in indirect hemagglutination tests with normal and tanned red blood cells. J Bacteriol. 1967 Sep;94(3):499–505. doi: 10.1128/jb.94.3.499-505.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965 Jun;23(Suppl):285+–285+. [PubMed] [Google Scholar]
  7. KLIENEBERGER-NOBEL E. Pathogenicity and immunology of organisms of the pleuropneumonia group. Ann N Y Acad Sci. 1960 Jan 15;79:615–625. doi: 10.1111/j.1749-6632.1960.tb42731.x. [DOI] [PubMed] [Google Scholar]
  8. PARKES M. W., WRIGLEY F., O'BRIEN B. Arthritis in rats produced by pleuro-pneumonia-like organisms. Ann Rheum Dis. 1951 Jun;10(2):177–181. doi: 10.1136/ard.10.2.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Purcell R. H., Taylor-Robinson D., Wong D. C., Chanock R. M. A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. Am J Epidemiol. 1966 Jul;84(1):51–66. doi: 10.1093/oxfordjournals.aje.a120627. [DOI] [PubMed] [Google Scholar]
  10. ROWLEY D., JENKIN C. R. Antigenic cross-reaction between host and parasite as a possible cause of pathogenicity. Nature. 1962 Jan 13;193:151–154. doi: 10.1038/193151a0. [DOI] [PubMed] [Google Scholar]
  11. TAYLOR-ROBINSON D., LUDWIG W. M., PURCELL R. H., MUFSON M. A., CHANOCK R. M. SIGNIFICANCE OF ANTIBODY TO MYCOPLASMA HOMINIS TYPE 1 AS MEASURED BY INDIRECT HEMAGGLUTINATION. Proc Soc Exp Biol Med. 1965 Apr;118:1073–1083. doi: 10.3181/00379727-118-30049. [DOI] [PubMed] [Google Scholar]
  12. Taylor-Robinson D., Berry D. M. The evaluation of the metabolic-inhibition technique for the study of Mycoplasma gallisepticum. J Gen Microbiol. 1969 Jan;55(1):127–137. doi: 10.1099/00221287-55-1-127. [DOI] [PubMed] [Google Scholar]
  13. WARD J. R., JONES R. S. The pathogenesis of mycoplasma (PPLO) arthritis in rats. Arthritis Rheum. 1962 Apr;5:163–175. doi: 10.1002/art.1780050205. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES